Get the Stockscreener App
916.00
3.90%
-37.19
After Hours:
917.00
1.00
+0.11%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $916.00, with a volume of 1.55M.
It is down -3.90% in the last 24 hours and up +10.95% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$953.19
Open:
$953.32
24h Volume:
1.55M
Relative Volume:
2.09
Market Cap:
$112.20B
Revenue:
$397.96B
Net Income/Loss:
$4.55B
P/E Ratio:
26.35
EPS:
34.7654
Net Cash Flow:
$9.64B
1W Performance:
-4.36%
1M Performance:
+10.95%
6M Performance:
+39.00%
1Y Performance:
+53.95%
1-Day Range:
$894.59
$968.61
1-Week Range:
$894.59
$971.93
52-Week Range:
$585.23
$971.93
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
916.00 | 116.75B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
351.06 | 71.14B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
215.06 | 52.77B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
78.43 | 9.62B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.44 | 1.21B | 2.22M | -5.63M | -1.68M | -0.24 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
McKesson Freed From Opioid Death Suit By Ga. Panel - Law360
BofA remains bullish on McKesson (MCK) following strong third quarter performance - MSN
McKesson (MCK) Is Up 9.9% After Strong Q3 Earnings, Capital Returns And New Shelf Filing – Has The Bull Case Changed? - Yahoo Finance
McKesson Refocuses On North America With Spin Off And Oncology Growth - simplywall.st
5 Insightful Analyst Questions From McKesson's Q4 Earnings Call - Finviz
Rhumbline Advisers Sells 2,293 Shares of McKesson Corporation $MCK - MarketBeat
McKesson Corporation $MCK Shares Sold by Wealthfront Advisers LLC - MarketBeat
McKesson Corporation $MCK Shares Bought by Prospera Financial Services Inc - MarketBeat
Caprock Group LLC Makes New Investment in McKesson Corporation $MCK - MarketBeat
ING Groep NV Grows Stake in McKesson Corporation $MCK - MarketBeat
5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call - Yahoo Finance
The Beginning of the End for Big Corporate Medicine - BIG substack.
JP Morgan Raises Price Target for McKesson (MCK) to $1107 | MCK Stock News - GuruFocus
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson price target raised to $1,107 from $983 at JPMorgan - TipRanks
JPMorgan Adjusts Price Target on McKesson to $1,107 From $983, Maintains Overweight Rating - marketscreener.com
Applied Finance Capital Management LLC Has $14.16 Million Stock Position in McKesson Corporation $MCK - MarketBeat
Robots and pharma logistics: is the future inside a McKesson warehouse? - Pharmaceutical Technology
Insider Sell Alert: Rutledge Napoleon B JR Sells Shares of McKes - GuruFocus
McKesson (NYSE:MCK) CAO Napoleon Rutledge Jr Sells 328 Shares - MarketBeat
McKesson’s Portfolio Shake-Up: Can Focused Platforms Deliver Faster, Smarter Expansion? - Smartkarma
McKesson (MCK) Is Up 12.1% After Strong Q3 EPS And Capital Moves Has The Bull Case Changed? - simplywall.st
McKesson’s (MCK) More Powerful Than President Trump, Says Jim Cramer - MSN
McKesson Corporation $MCK Shares Acquired by Kinsale Capital Group Inc. - MarketBeat
Canada Post Corp Registered Pension Plan Purchases 1,500 Shares of McKesson Corporation $MCK - MarketBeat
Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Biogen (BIIB) - The Globe and Mail
McKesson Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Market Outlook: Will McKesson Corporation benefit from rising consumer demandJuly 2025 Intraday Action & Technical Buy Zone Confirmation - baoquankhu1.vn
McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK) - TechStock²
How McKesson Stock Surged 17% In A Day - Forbes
MCK Q3 Earnings & Sales Top Estimates, 2026 View Up - TradingView
McKesson stock price target raised to $1,012 from $1,000 at TD Cowen - Investing.com Nigeria
Wells Trecaso Financial Group LLC Has $4.81 Million Holdings in McKesson Corporation $MCK - MarketBeat
McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook - TechStock²
McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum - FinancialContent
Why McKesson (MCK) is a Top Growth Stock for the Long-Term - Yahoo Finance
McKesson Stock’s 17% Earnings Rip: Is The “Boring” Distributor Dead? - Trefis
S&P 500 Drops 1.23% Amid 3,176 Declines; McKesson Corp. Soars 16.52% - Markets Mojo
McKesson raises FY26 EPS outlook following quarterly beats - MSN
McKesson Stock (+17%): Raised FY26 EPS Outlook Ignites Institutional Chase - Trefis
McKesson Corporation $MCK Shares Bought by C WorldWide Group Holding A S - MarketBeat
J.W. Cole Advisors Inc. Purchases 1,329 Shares of McKesson Corporation $MCK - MarketBeat
McKesson (MCK) Receives Updated Analyst Rating from Mizuho | MCK Stock News - GuruFocus
McKesson Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
How McKesson Stock Gained 40% - Trefis
Decoding McKesson Corp (MCK): A Strategic SWOT Insight - GuruFocus
McKesson Earnings Call Highlights Specialty and Tech Strength - TipRanks
McKesson stock jumps 16% after forecast lift — traders eye the next catalyst for MCK - TechStock²
McKesson Corporation Clears European Hurdles and Raises FY26 EPS Guidance - timothysykes.com
McKesson Corporation: Margaret Buckley drives cancer care impact - Traders Union
McKesson Reports Strong Q3 Earnings, Lifts FY26 EPS Outlook - StocksToTrade
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.00%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):